ATE366320T1 - Verfahren zur erhöhung der genexpression der transfizierten genen - Google Patents

Verfahren zur erhöhung der genexpression der transfizierten genen

Info

Publication number
ATE366320T1
ATE366320T1 AT01910129T AT01910129T ATE366320T1 AT E366320 T1 ATE366320 T1 AT E366320T1 AT 01910129 T AT01910129 T AT 01910129T AT 01910129 T AT01910129 T AT 01910129T AT E366320 T1 ATE366320 T1 AT E366320T1
Authority
AT
Austria
Prior art keywords
gene expression
transfected genes
increase gene
transfected
genes
Prior art date
Application number
AT01910129T
Other languages
English (en)
Inventor
C Pisano
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE366320T1 publication Critical patent/ATE366320T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01910129T 2000-02-17 2001-02-09 Verfahren zur erhöhung der genexpression der transfizierten genen ATE366320T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000077A IT1316990B1 (it) 2000-02-17 2000-02-17 Metodo per aumentare l'espressione genica per geni trasfettati.

Publications (1)

Publication Number Publication Date
ATE366320T1 true ATE366320T1 (de) 2007-07-15

Family

ID=11454443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01910129T ATE366320T1 (de) 2000-02-17 2001-02-09 Verfahren zur erhöhung der genexpression der transfizierten genen

Country Status (19)

Country Link
US (2) US20030022859A1 (de)
EP (1) EP1257658B1 (de)
JP (1) JP4726378B2 (de)
KR (1) KR100768264B1 (de)
AT (1) ATE366320T1 (de)
AU (1) AU2001237712A1 (de)
CA (1) CA2400110A1 (de)
CY (1) CY1106872T1 (de)
CZ (1) CZ303403B6 (de)
DE (1) DE60129206T2 (de)
DK (1) DK1257658T3 (de)
ES (1) ES2288164T3 (de)
HU (1) HUP0204460A2 (de)
IT (1) IT1316990B1 (de)
MX (1) MXPA02007959A (de)
PL (1) PL204125B1 (de)
PT (1) PT1257658E (de)
SK (1) SK287759B6 (de)
WO (1) WO2001061025A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316990B1 (it) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti Metodo per aumentare l'espressione genica per geni trasfettati.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000137A1 (de) * 1993-06-21 1995-01-05 Bernardini, Attilio Verwendung von acylcarnitin zur behandlund von aids-krankheiten
EP0681839A3 (de) * 1994-05-12 1997-11-12 Hirohiko Kuratsune Acylcarnitin-enthaltende pharmazeutische Zusammensetzung
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
WO1999007094A2 (en) 1997-07-31 1999-02-11 Larkom, L.L.C. Shared high speed network access
EP0996739A2 (de) * 1998-05-06 2000-05-03 Transgene S.A. Verbesserungen der gentherapie durch verwendung der zusammensetzungen die ein polynukleotid und ein nukleasehemmer oder interleukin-10 enthalten
IT1299172B1 (it) * 1998-05-06 2000-02-29 Sigma Tau Ind Farmaceuti Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti
EP1091762A1 (de) * 1998-07-02 2001-04-18 Genzyme Corporation Expression von transgenen in polarisierten zellen
IT1316990B1 (it) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti Metodo per aumentare l'espressione genica per geni trasfettati.

Also Published As

Publication number Publication date
ES2288164T3 (es) 2008-01-01
KR100768264B1 (ko) 2007-10-18
SK11872002A3 (sk) 2002-11-06
US7560439B2 (en) 2009-07-14
WO2001061025A1 (en) 2001-08-23
SK287759B6 (sk) 2011-09-05
US20030022859A1 (en) 2003-01-30
US20050124570A1 (en) 2005-06-09
HUP0204460A2 (en) 2003-04-28
ITRM20000077A1 (it) 2001-08-17
AU2001237712A1 (en) 2001-08-27
CZ303403B6 (cs) 2012-08-29
EP1257658B1 (de) 2007-07-04
JP4726378B2 (ja) 2011-07-20
EP1257658A1 (de) 2002-11-20
IT1316990B1 (it) 2003-05-26
DK1257658T3 (da) 2007-11-05
KR20030072204A (ko) 2003-09-13
PT1257658E (pt) 2007-09-14
CZ20022757A3 (cs) 2003-02-12
JP2003522544A (ja) 2003-07-29
DE60129206T2 (de) 2008-03-06
MXPA02007959A (es) 2003-02-10
PL365011A1 (en) 2004-12-27
CA2400110A1 (en) 2001-08-23
ITRM20000077A0 (it) 2000-02-17
PL204125B1 (pl) 2009-12-31
DE60129206D1 (de) 2007-08-16
CY1106872T1 (el) 2012-09-26

Similar Documents

Publication Publication Date Title
ATE429444T1 (de) Neues carbamyliertes epo und verfahren zu dessen herstellung
DK1409670T3 (da) Syntetiske dobbeltstrengede oligonukleorider til målrettet hæmning af genekspressionen
EP1504126A4 (de) Verfahren zur regulation der genexpression
DK1404324T3 (da) Prolægemidler af GABA analoger, sammensætninger og anvendelser deraf
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE50213524D1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
DE60122242D1 (de) Verfahren zur Bekämpfung von Saatkrankheiten
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
BRPI0408466B8 (pt) composição farmacêutica e uso de inibidor de proteína de transferência de colesteril éster e crospovidona
DE60018902D1 (de) Verfahren zur herstellung von nitroxymethylphenylestern von aspirinderivaten
DE60129032D1 (de) Creatinester-pronutrient-verbindungen und formulierungen
CY1107776T1 (el) Νεα παραγωγα ολιγο-νουκλεοτιδιων για στοχευμενη αναστολη της εκφρασης γονιδιων
DE60129206D1 (de) Verfahren zur erhöhung der genexpression der transfizierten genen
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
BR0208593A (pt) método para o tratamento de um mamìfero, composto, e, composição farmacêutica
DE10290206D2 (de) Verfahren zur Regelung der Fahrstabilität
PL372933A1 (en) Methylthiophene carboxanilides
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας
DE50206615D1 (de) Verfahren zur Herstellung von 15-Pentadecanolid
DE60031262D1 (de) Menschliche promotoren des gaba b-rezeptors 1
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
DE60233636D1 (de) Verfahren zur herstellung von zahnbleichmitteln
DE60108515D1 (de) Verfahren zur herstellung eines pgd2-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1257658

Country of ref document: EP